Muscle Relaxants Interactions

Avoid concomitant use.

Source: NLP:hydrocodone polistirex and chlorpheniramine polistirex

Concomitant use increases risk of respiratory depression, profound sedation, coma, and death due to additive CNS depressant effects.

Source: NLP:buprenorphine and naloxone

Concomitant use increases risk of respiratory depression, profound sedation, coma, and death due to additive CNS depressant effects.

Source: NLP:buprenorphine hcl

Avoid concomitant use with hydrocodone bitartrate and homatropine methylbromide.

Source: NLP:hydrocodone bitartrate and homatropine methylbromide

Avoid concomitant use with hydrocodone bitartrate and homatropine methylbromide.

Source: NLP:hydrocodone bitartrate and homatropine methylbromide oral solution

Enhanced neuromuscular blocking action and increased respiratory depression.

Source: NLP:levorphanol tartrate

CNS depressant effect increases risk of respiratory depression, profound sedation, coma, and death.

Source: NLP:methadone hydrochloride

Morphine may enhance neuromuscular blocking action and produce increased degree of respiratory depression.

Source: NLP:morphine sulfate

Nalbuphine may enhance neuromuscular blocking action and produce increased respiratory depression. Monitor for respiratory depression greater than expected.

Source: NLP:nalbuphine hydrochloride

Concomitant use may enhance neuromuscular blocking action and produce increased respiratory depression. Monitor for signs of respiratory depression.

Source: NLP:pentazocine and naloxone

Avoid concomitant use due to potential adverse effects.

Source: NLP:promethazine hydrochloride and codeine phosphate

Avoid concomitant use with this combination product.

Source: NLP:promethazine, phenylephrine, codeine

Concurrent use may potentiate CNS adverse reactions and increase risk of intestinal obstruction and urinary retention. More frequent monitoring recommended.

Source: NLP:scopolamine

May potentiate JEUVEAU's effects. Close observation recommended during concomitant use.

Source: NLP:prabotulinum toxin type a

May potentiate CNS depressant effects of diphenoxylate hydrochloride and atropine sulfate. Monitor for CNS adverse reactions.

Source: NLP:diphenoxylate hydrochloride and atropine sulfate

May enhance neuromuscular blocking action and increase respiratory depression.

Source: NLP:hydromorphone hydrochloride

Muscle relaxants administered before or after incobotulinumtoxina may exaggerate excessive weakness.

Source: NLP:incobotulinumtoxina

Additive drowsiness and CNS depression reported with concurrent use.

Source: NLP:nabilone

Administration before or after BOTOX may exaggerate excessive weakness. Close observation recommended.

Source: NLP:onabotulinumtoxina

Concurrent use may potentiate CNS adverse reactions including drowsiness, dizziness, or disorientation due to anticholinergic properties.

Source: NLP:scolopamine transdermal system

Effects of non-depolarizing skeletal muscle relaxants may be potentiated when given with triamterene.

Source: NLP:triamterene

Interactions have been observed with nondepolarizing muscle relaxants.

Source: NLP:rocuronium bromide